CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda.
Rio De Janeiro, Brazil
Medical center in Rio de Janeiro, State of Rio de Janeiro
R. da Glória, 344 - Glória, Rio de Janeiro - RJ, 20241-180
About CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda.
"O IBPClin um Centro de Pesquisa Clínica, dedicado à condução de grandes estudos multicêntricos para desenvolvimento de novos medicamentos para a indústria farmacêutica."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda.
During the past decade, CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 16 clinical trials were completed, i.e. on
average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
2004-08-01
2009-05-01
Completed
100
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
2008-09-03
2016-02-25
Completed
723
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2010-01-01
2015-12-01
Completed
1,069
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2009-09-01
2016-01-01
Completed
347
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
2009-09-30
2017-11-02
Completed
1,199
A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
2011-01-13
2016-11-30
Completed
343
Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer
2012-11-23
2019-02-12
Completed
156
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
2013-02-22
2023-08-26
Active, not recruiting
666
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda." #1 sponsor was "Pfizer" with 5 trials, followed by "Mannkind Corporation" with 4 trials
sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "R-Pharm International, LLC"
with 3 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda."
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda.
According to Clinical.Site data, the most researched conditions in "CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda." are
"Arthritis, Rheumatoid" (4 trials), "Diabetes Mellitus, Type 2" (4 trials), "Rheumatoid Arthritis" (3 trials), "Cardiovascular Disease" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda." in a lesser frequency.
Clinical Trials Intervention Types at CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda.
Most popular intervention types in "CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda." are "Drug" (21 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Technosphere Insulin" (3 trials), "CP-690,550" (2 trials), "Empagliflozin" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda.
The vast majority of trials in "CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda." are
21 trials for "All" genders.
Clinical Trials Status at CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda.
Currently, there are NaN active trials in "CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda.".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 16 completed trials in CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda.,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda., 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".